Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosine deaminase domain containing 1 pseudogene 2 (ADAD1P2) is a human pseudogene resembling the functional adenosine deaminase domain containing 1 gene but does not encode a functional protein product. Pseudogenes like ADAD1P2 are typically DNA remnants of once-functional genes, arising via gene duplication, retrotransposition, or mutation, and generally lack regulatory sequences or protein-coding capability. While most pseudogenes are transcriptionally silent and considered non-functional, a minority may have regulatory roles, though ADAD1P2 is not known to have any. It is not a drug target, receptor, enzyme, or marker for disease or therapy. This entry should be distinguished from the active protein family (adenosine deaminase domain containing 1, ADAD1), which is an enzyme involved in RNA editing—but ADAD1P2 itself is non-functional and not a conventional molecular target.
None; as it is not a functional target, no mechanism of drug action applies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine deaminase domain containing 1 pseudogene 2 (ADAD1P2).